ARTERIAL HYPERTENSION WORKGROUP RESOLUTION. THE ROLE OF SARTANS IN TREATMENT OF SYSTEMIC HYPERTENSION IN THE 21ST CENTURY
.
Main Authors: | A. O. Konradi, O. N. Zhdanova, O. P. Rotar, Yu. A. Karpov, V. I. Podzolkov, P. A. Lebedev, A. I. Chesnikova, D. V. Nebieridze, O. N. Miller, E. V. Solovjova, A. N. Kulikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2018-04-01
|
Series: | Российский кардиологический журнал |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2754 |
Similar Items
-
State stiffness parameters of the vascular wall in hypertensive patients complex therapy cytoprotector and sartans
by: V. P. Mikhin, et al.
Published: (2015-10-01) -
Possibilities ARB II (sartans) in hypertensive patients
by: T E Morozova, et al.
Published: (2014-09-01) -
Rationale for the use of sartans in patients with arterial hypertension
by: Raisa Ivanovna Stryuk
Published: (2009-12-01) -
Sartans in the treatment of high-risk hypertension: the abilities of candesartan
by: T E Morozova
Published: (2013-06-01) -
FEATURES OF ARTERIAL HYPERTENSION IN PATIENTS WITH COMORBIDITY
by: A. I. Chesnikova, et al.
Published: (2017-03-01)